MOMS 2: A Follow-up to the Management of Myelomeningocele Study
Phase two of the Management of Myelomeningocele Study (MOMS 2), sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, is a multicenter study that continues to monitor health outcomes of the children and mothers who participated in the randomized trial. (Learn more about phase one of the MOMS trial.)
The purpose of MOMS 2 is to compare the long-term effects of prenatal surgery and postnatal surgery for myelomeningocele with respect to the child’s adaptive behavior, physical and cognitive function, health and well-being, and the future reproductive health of the mother.
This important follow-up study, continuing through November 2016, will provide valuable insight into the lasting outcomes of prenatal repair versus standard postnatal repair in children 6 to 10 years of age, and provide both clinical teams and families with additional information to make better informed choices about the treatment options available in the future.
Read some of the most recent reports coming out of this ongoing study.